AVROBIO Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	12.16	-105.89	-119.13	-119.71	-72.97	-48.6	-18.73	-4.97
Depreciation & Amortization	2.53	4.17	1.4	1.21	0.85	0.38	0.05	0
Share-Based Compensation	6.89	11.52	18.58	15.63	6.8	2.2	0.18	0.07
Other Operating Activities	-84.77	-7.01	1.12	4.07	-2.35	6.14	2.04	1.28
Operating Cash Flow	-63.19	-97.21	-98.03	-98.8	-67.67	-37.65	-16.38	-3.31
Capital Expenditures	1.34	-0.27	-2.46	-1.18	-1.59	-1.83	-0.38	0
Other Investing Activities	83.74	-	-	-	-	-	-	-0.02
Investing Cash Flow	85.08	-0.27	-2.46	-1.18	-1.59	-1.83	-0.38	-0.02
Share Issuance / Repurchase	0.32	0.26	15.47	172.62	129.99	104.03	0	0
Debt Issued / Paid	-16.35	0	14.9	0	0	0	-0.04	0
Other Financing Activities	-	-	-	-	-	56.26	17.42	8.7
Financing Cash Flow	-16.03	0.26	30.37	172.62	129.99	160.29	17.37	8.7
Net Cash Flow	5.86	-97.21	-70.12	72.64	60.74	120.81	0.61	5.36
Free Cash Flow	-61.85	-97.48	-100.49	-99.98	-69.25	-39.48	-16.77	-3.31
Free Cash Flow Per Share	-1.40	-2.23	-2.35	-2.76	-2.52	-2.94	-7.50	-1.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).